Skip to content

IDEXX Laboratories Inc

US · IDXX #543 by market cap Listed 1970
676.21 -13.44 -1.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 687.37 -0.33%
After-hours 674.72 -0.22%
706.65504.70676.212026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on IDXX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +11.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 3.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 45.6x Better than 11%
Forward P/E 41.6x Better than 10%
Price / Sales 11.4x Better than 9%
P/E vs own 5-yr range 34th pctl Better than 73%
Growth A-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 8.5% Better than 60%
Net income CAGR (3Y) 16.0% Better than 67%
Free cash flow CAGR (3Y) 39.5% Better than 80%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 61.8% Better than 76%
Operating margin 31.6% Better than 91%
Net margin 24.6% Better than 84%
Return on equity 66.2% Better than 96%
Return on invested capital 42.1% Better than 98%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 21.4% Better than 97%
6-month return 20.9% Better than 83%
12-month return (ex latest month) -22.8% Better than 13%
Distance below 52-week high 12.2% Better than 78%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.2x Better than 30%
Debt to assets 29.1% Better than 43%
Interest coverage 35.1x Better than 88%
Free cash flow / net income 98.5% Better than 37%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 75.0% Better than 51%
Upside to average target 10.2% Better than 15%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -3.98%
1M +21.20%
3M +23.88%
6M +22.15%
YTD -0.05%
1Y -1.91%
3Y +42.98%
5Y +4.47%

Key statistics

Price & volume

Prev close
689.65
Open
688.61
Day range
672.72 - 696.89
Avg price
680.20
Volume
614.36K
Turnover
417.89M
Amplitude
3.51%
52-week range
500.61 - 769.98

Valuation

P/E
51.70
P/E (TTM)
45.57
P/B
28.50
EPS
13.08
Net profit
1.03B
Net assets
1.87B

Share structure

Market cap
53.28B
Float cap
53.09B
Shares out
78.79M
Float shares
78.52M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 65% of range
500.61 769.98

12.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+8.82M net over the window

Short interest

Shares short
2.35M
As of
2026-10-30

Frequently asked questions

What is the current stock price of IDEXX Laboratories Inc (IDXX)?

IDEXX Laboratories Inc last traded at 676.21. This page shows a periodic quote snapshot. Check the displayed quote time.

What is IDEXX Laboratories Inc's market cap?

About 53.28B.

What is the P/E ratio of IDEXX Laboratories Inc?

The trailing twelve-month P/E is 45.57, below its own 5-year average of 49.92 — in the middle of its historical range (33.63% percentile). See the Valuation tab for the full history.

Does IDEXX Laboratories Inc pay a dividend?

IDEXX Laboratories Inc does not currently pay a regular dividend.

Is IDEXX Laboratories Inc a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 745.00, which implies 10.2% upside from the current price. This is not investment advice.

What is IDEXX Laboratories Inc's StockVane Quant Rating?

The StockVane Momentum strategy currently rates IDEXX Laboratories Inc a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.

IDEXX Laboratories Inc discussion 0 comments

Add a comment